The Sun Yat-sen University Cancer Center (SYSUCC) has entered into cooperation with MedBridge Shanghai. Founded in March 1964 as one of the four earliest cancer hospitals of the People's Republic of China, it now operates two campuses: Yuexiu (651 Dongfeng East Road) and Huangpu, with a third Tianhe campus under construction.
The center operates 2,245 licensed beds, serving 2.558 million outpatient/emergency visits and 222,000 inpatients annually. Its clinical volume ranks among the top cancer hospitals nationwide, making it the largest and most academically robust oncology center in South China.
It hosts the national key discipline of oncology, the State Key Laboratory of Oncology in South China, and the National Clinical Research Center for Anti-cancer Drugs, and publishes the English journal Cancer Communications (JCR Oncology Q1). SYSUCC is a sister hospital of The University of Texas MD Anderson Cancer Center and collaborates with the Karolinska Institute and the University of Warwick.
SYSUCC is among the first cancer hospitals in China — and the first in South China — accredited by the Royal College of Surgeons (UK). It runs an Asia-class radiation therapy center and multiple robotic minimally invasive platforms. International cancer patients can book multidisciplinary consultations, radiation therapy and surgery through MedBridge, supported by translation, accompaniment and post-treatment follow-up.